<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJMC</journal-id><journal-title-group><journal-title>Open Journal of Medicinal Chemistry</journal-title></journal-title-group><issn pub-type="epub">2164-3121</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojmc.2015.53004</article-id><article-id pub-id-type="publisher-id">OJMC-60062</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>.</surname><given-names>Manimaran</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>A.</surname><given-names>Ganapathi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>T.</surname><given-names>Balasankar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Chemistry Section, FEAT, Annamalai University, Annamalai Nagar, India</addr-line></aff><aff id="aff1"><addr-line>Department of Chemistry, Annamalai University, Annamalai Nagar, India</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>maransuman@gmail.com(AG)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>30</day><month>09</month><year>2015</year></pub-date><volume>05</volume><issue>03</issue><fpage>33</fpage><lpage>47</lpage><history><date date-type="received"><day>17</day>	<month>August</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>27</month>	<year>September</year>	</date><date date-type="accepted"><day>30</day>	<month>September</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p><html>
 <head></head>
 
  To exploit the potential biological activities of azabicyclic based, seven 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone were synthesized. The structural elucidation and stereochemistry of these compound assigned by FT-IR, 
  <sup>1</sup>H, 
  <sup>13</sup>C and 2D NMR spectral data. The Structural Activity Relationship (SAR) of the target compounds were examined for their 
  in vitro anti-proliferative, antioxidant and antimicrobial activities. The initial screen was treated against human liver cancer cell lines (HepG2) with IC
  <sub>50</sub> values determined by MTT assay. Fluoro substitution at para position of phenyl ring compound 12 showed more antiproliferative activity against HepG2 at half maximum inhibitory concentration (IC
  <sub>50</sub> = 3.76 μg/mL) than other target hydrazones. The mechanism of the antitumor action of active compound 12 was investigated through Hoechst stain 33342 analyses. It indicated that the compound inhibited HepG2 cancer cells proliferation by triggering apoptotic cell death. The Free radical scavenging activity of all synthesized compounds were evaluated with 
  <img src="Edit_93c6f4c8-2935-4a3c-833e-9aea56a04c60.jpg" width="38" alt="" />, 
  <img src="Edit_e99385dd-bb24-4b0f-855d-04e38e20617d.jpg" width="25" height="14" alt="" /> and 
  <img src="Edit_42717dc4-a3b6-470e-9113-57b42f8bb252.jpg" width="22" height="17" alt="" /> radicals. The compounds 11 (IC
  <sub>50</sub> rang 3.78 - 4.31 μg/mL) and 15 (IC
  <sub>50</sub> rang 4.61 - 5.16 μg/mL) were exhibited higher free radical scavenging activity than standard BHT drug. Besides, all the target compounds were screened for their 
  in vitro antibacterial and antifungal activity against a spectrum of microbial organisms by using twofold dilution method. These studies proved that halogen substituted compounds 12, 13 and 14 were showed excellent inhibitory potency at lowest minimum inhibitory concentration (MIC) range of 6.25 - 25.5 μg/mL. Nevertheless, multiple mechanisms regulating the antioxidant and anticancer effects of the hybrid molecules need to be further investigations.
 
</html></p></abstract><kwd-group><kwd>2-Thienoyl Hydrzones</kwd><kwd> Antioxidant</kwd><kwd> Anticancer</kwd><kwd> Cytotoxicity</kwd><kwd> Antimicrobial Activity</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>At present, human liver cancer is a major reason for death worldwide. The proportion of people suffering from cancer is estimated to continue growing largely because of the aging of population in most countries [<xref ref-type="bibr" rid="scirp.60062-ref1">1</xref>] . Reactive oxygen, nitrogen and sulphur (NOS) are important for an organism’s vital activities such as the regulation of biological active compounds. Extreme production of reactive oxygen species causes oxidative stress, chronic diseases and cancer. NOS containing molecules are well known to directly interact with all types of biological molecules, proteins, DNA and lipids [<xref ref-type="bibr" rid="scirp.60062-ref2">2</xref>] -[<xref ref-type="bibr" rid="scirp.60062-ref4">4</xref>] . The shared adverse effects are termed oxidative stress. Oxidative stress has involved in the various hallmark abilities of cancer [<xref ref-type="bibr" rid="scirp.60062-ref2">2</xref>] -[<xref ref-type="bibr" rid="scirp.60062-ref4">4</xref>] . Research over the past numerous decades has established that antioxidants play a protective role in multistage carcinogenesis [<xref ref-type="bibr" rid="scirp.60062-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.60062-ref4">4</xref>] . Generally, a living organism has protective enzymatic and non-enzymatic antioxidant mechanisms against Reactive Oxygen Species (ROS) induced oxidative damage. Recently, significant attention has focused on identifying synthetic antioxidants that aim several signaling pathways are abnormal in cancer.</p><p>The 3-azabicyclo [3.3.1] nonane pharmacophore is present in a wide variety of naturally occurring diterphenoid/nor diterphenoid alkaloids and biological activities [<xref ref-type="bibr" rid="scirp.60062-ref5">5</xref>] -[<xref ref-type="bibr" rid="scirp.60062-ref7">7</xref>] . 2, 4-Diaryl-3-azabicyclo [3.3.1] nonan-9-one derivatives are showed excellent antitumor [<xref ref-type="bibr" rid="scirp.60062-ref8">8</xref>] and antimicrobial [<xref ref-type="bibr" rid="scirp.60062-ref9">9</xref>] activities. Correlation between cytotoxicity and antioxidant capacity of natural/synthetic compounds [<xref ref-type="bibr" rid="scirp.60062-ref10">10</xref>] , we are discovered strong cytotoxicity with poor antioxidant properties of synthesized halogen substituted such as F, Cl and Br compounds may be due to the pro-oxidant effects. Although potent antioxidant often possess strong pro-oxidant activity, found low cytotoxicity in synthetic compounds with electron donating functional groups (-CH<sub>3</sub>, -OCH<sub>3</sub> and CH(CH<sub>3</sub>)<sub>2</sub>) present on the aryl rings attached to azabicyclo [3.3.1] nonane-9-ones in line with the observations of Lee et al. [<xref ref-type="bibr" rid="scirp.60062-ref11">11</xref>] Though, multiple mechanisms regulating the antioxidant and cytotoxic effects of the hybrid molecules necessitate to be further investigations.</p><p>The half maximum inhibitory concentration (IC<sub>50</sub>) has measured the effectiveness of synthesized compounds in inhibiting specific biological functions of anticancer activity and free radical scavenging activity. This quantitative measurement indicates how much of a particular drug is need to inhibit a given biological microorganisms by half. It is generally used as a measure of antagonist drug potency in pharmacological research work. The IC<sub>50</sub> values of drug (synthesized target compounds) can be determined by constructing a dose response and investigate the effect of different concentrations of antagonist on reversing agonist activity. IC<sub>50</sub> values can be measured for a given antagonist by determining the concentration required to inhibit half of the maximum biological response of the agonist. Hepatocellular carcinoma (HepG2) is derived from the liver tissue of human. This cell lines obtained from National centre for cell sciences (NCCS), Pune, India and it is a best suitable cell lines to evaluate the cytotoxicity of synthesized compounds. The use of electron donating and withdrawing substituent at aromatic compounds with regards to biological activity has established [<xref ref-type="bibr" rid="scirp.60062-ref12">12</xref>] and several interesting investigations are made through piperidine based heterocyclic compounds and exhibited antimicrobial, antioxidant, antithrombic, calcium antagonist, hypotensive and neuroleptic activities [<xref ref-type="bibr" rid="scirp.60062-ref13">13</xref>] - [<xref ref-type="bibr" rid="scirp.60062-ref16">16</xref>] . Hydrazone are noteworthy molecule containing extremely reactive azomethyne (-CONHNC&lt;) are one useful in drug development [<xref ref-type="bibr" rid="scirp.60062-ref17">17</xref>] . 2-Thiophenecarboxylic acid hydrazide has involved significant attention due to the biological activity which has been widely recognized and practically applied in a number of drugs [<xref ref-type="bibr" rid="scirp.60062-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.60062-ref19">19</xref>] .</p><p>In this paper, we report synthesis of seven 2r, (Scheme 1) 4c-Diaryl-3-azabicyclo [3.3.1] nonan-9-one-2’- thienoyl hydrazones highlights the in vitro antioxidant, antitumor and antimicrobial activities against three kinds of free radicals, human liver hepatocellular carcinoma (HepG2) cell lines, bacteria and fungi strain organisms, respectively.</p></sec><sec id="s2"><title>2. Experimental Methods</title><sec id="s2_1"><title>2.1. Chemistry</title><sec id="s2_1_1"><title>2.1.1. Chemicals Equipment Techniques for Structural Elucidation</title><p>2-Thiophenecarboxylic acid hydrazide, substituted aldehydes and solvents were purchased from Sigma-Aldrich<sup>&#174;</sup>, Himedia<sup>&#174;</sup> and Merck<sup>&#174;</sup>, Germany, were used directly without further recrystellization. Reaction process and purity were monitored by thin layer chromatography (TLC). Physical properties of melting point were determined in an Electro thermal 9100 instrument in open capillaries and are uncorrected. FT-IR analysis has been recorded in an IR-470 SHIMADZU spectrometer (Shimadzu, Tokyo, Japan.) by making pellet of compound with KBr</p><disp-formula id="scirp.60062-formula39"><graphic  xlink:href="http://html.scirp.org/file/1-1790084x7.png"  xlink:type="simple"/></disp-formula><p>Scheme 1. Synthesis of 2r, 4c-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazones (9-15).</p><p>and values are expressed as v<sub>max</sub> cm<sup>−1</sup>. <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectra were recorded at ambient temperature on a Bruker AMX-400 NMR spectrometer operating at 400.13MHz for <sup>1</sup>H and 100.62 MHz for <sup>13</sup>C. Chemical shift (δ) unit expressed in parts per million (ppm) with respect to TMS. Sample was prepared in CDCl<sub>3</sub> solvent (10 mg in 0.5 mL). Elemental analysis for all synthesized compounds was performed on an Elementor Vario EL-III CHNS analyzer.</p></sec><sec id="s2_1_2"><title>2.1.2. General Procedure for Synthesized Compound 2r, 4c-Diaryl-3-Azabicyclo [3.3.1] Nonan-9-One-2’-Thienoyl Hydrazones (9-15)</title><p>First 2r, 4c-Diaryl-3-azabicyclo [3.3.1]nonan-9-ones (1-7) were prepared by the condensation of appropriate cyclohexanone (1equiv), respective aromatic aldehyde (2equiv) and Ammonium acetate (1.5equiv) dissolved in ethanol was kept in water bath by maintaining the bath temperature at 60˚C - 75˚C with continuous stirring using literature procedure [<xref ref-type="bibr" rid="scirp.60062-ref20">20</xref>] . The crude product precipitated from the solvent was filtered. It was washed through etheric ethanol solution. An ethanol/chloroform/acetone mixture ratio (2:1:1) was used for recrystallization of 1-7 compounds. A mixture of 2r, 4c-Diaryl-3-azabicyclo [3.3.1] nonan-9-one (1 mmol) and 2-Thiophe- necarboxylic acid hydrazide (1.5 mmol) was dissolved in methanol and CHCl<sub>3</sub> (1:1v/v) and few drops of acetic acid was added as catalyst. The reaction mixture was refluxed for 2 - 3 h. On the completion of reaction a solid mass was formed. After the precipitate was filtered at room temperature and washed with cold mixture of water/ethanol mixture. The crude compounds were recrystallized from ethanol.</p><p>2r, 4c-Diphenyl-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 9</p><p>IR (KBr) (cm<sup>−1</sup>): 3034.03, 2924.09, 2854.65 (C-H stretching), 3302.13(-NH-), 1641.42 (C=O stretching), 1510.26 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.214 (s, 1H, HN-C=O), 4.490 (s, 1H, H-2a), 4.386 (s, 1H, H-4a), 3.342 (s, 1H, H-5e), 2.867 (d, 1H, H-7a), 2.76 (s, 1H, H-1e), 1.885 (s, 2H, H-8e, H-6a), 1.590 (m, 3H, H-8a, H-6e and ring NH) 1.417 (s, 1H, H-7e), 8.166 - 7.135 (m, 13H, aromatic and thienoyl ring protons). <sup>13</sup>C NMR (δppm): 65.47 (C-2), 63.60 (C-4), 46.09 (C-1), 38.48 (C-5), 28.56 (C-8), 27.34 (C-6), 21.56 (C-7), 142.39 (C-2ʹ), 141.31 (C-4ʹ), 163.56 (C-9), 161.81 (HN-C=O), 141.31 - 126.35 (aromatic and thienoyl ring carbons).</p><p>2r, 4c-Bis (p-methylphenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 10</p><p>IR (KBr) (cm<sup>−1</sup>): 3041.74, 2956.87, 2922.16 (C-H stretching), 3307.92 (-NH-), 1633.71 (C=O stretching), 1516.05 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.005 (s, 1H, HN-C=O), 4.476 (s, 1H, H-2a), 4.364 (s, 1H, H-4a), 3.278 (s, 1H, H-5e), 2.901 (s, 1H, H-7a), 2.751 (s, 1H, H-1e), 1.899 (s, 2H, H-8e, H-6a), 1.663 (m, 3H, H-8a, H-6e and ring NH) 1.442 (s, 1H, H-7e), 2.457 (d, 6H, p-<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x8.png" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x9.png" xlink:type="simple"/></inline-formula> are merged together) 8.233 - 7.139 (m, 11H, aromatic and thienoyl ring protons). <sup>13</sup>C NMR (δppm): 65.28 (C-2), 63.44 (C-4). 46.16 (C-1), 38.55 (C-5), 28.56 (C-8), 27.34 (C-6), 21.58 (C-7), 144.66 (C-2ʹ), 140.61 (C-4ʹ), 163.44 (C-9), 162.16 (HN-C=O), 21.18 (p-<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x10.png" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x11.png" xlink:type="simple"/></inline-formula> are merged together), 139.00 - 126.34 (aromatic and thienoyl ring carbons).</p><p>2r, 4c-Bis (p-methoxylphenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 11</p><p>IR (KBr) (cm<sup>−1</sup>): 3032.10, 2926.01, 2845 (C-H stretching), 3302.13 (-NH-), 1639.49 (C=O stretching), 1510.26 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 9.933 (s, 1H, HN-C=O), 4.447 (s, 1H, H-2a), 4.337 (s, 1H, H-4a), 3.231 (s, 1H, H-5e), 2.885 (bs, 1H, H-7a), 2.716 (s, 1H, H-1e), 1.902 (s, 2H, H-8e, H-6a), 1.774 - 1.567 (m, 3H, H-8a, H-6e and ring NH) 1.452 (s, 1H, H-7e), 3.879 (s, 6H, p-<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x12.png" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x13.png" xlink:type="simple"/></inline-formula> are merged together) 8.229 - 6.990 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 65.02 (C-2), 63.18 (C-4). 46.23 (C-1), 38.62 (C-5), 28.51 (C-8), 27.05 (C-6), 21.60 (C-7), 144.73 (C-2ʹ), 144.40 (C-4ʹ), 163.47 (C-9), 158.97 (HN-C=O), 55.42 (p-<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x14.png" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x15.png" xlink:type="simple"/></inline-formula> are merged together), 135.39 - 113.80 (aromatic and thienoyl ring carbons).</p><p>2r, 4c-Bis (p-fluorophenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 12</p><p>IR (KBr) (cm<sup>−1</sup>): 3024.38, 2920.23, 2848.86 (C-H stretching), 3300.20 (-NH-), 1633.71 (C=O stretching), 1510.26 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.311 (s, 1H, HN-C=O), 4.437 (t, 2H, H-2a and H-4a are merged together), 3.283 (s, 1H, H-5e), 2.849 (d, 1H, H-7a), 2.737 (s, 1H, H-1e), 1.915 (d, 2H, H-8e, H-6a), 1.758 - 1.676 (m, 3H, H-8a, H-6e and ring NH), 1.462 (d, 1H, H-7e), 8.244 - 7.144 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 64.14 (C-2), 62.97 (C-4), 46.04 (C-1), 38.38 (C-5), 28.94 (C-8), 27.05 (C-6), 21.11 (C-7), 143.38 (C-2ʹ), 141.40 (C-4ʹ), 163.43 (C-9), 160.99 (HN-C=O), 136.34 - 115.25 (aromatic and thienoyl ring carbons).</p><p>2r, 4c-Bis (p-chlorophenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 13</p><p>IR (KBr) (cm<sup>−1</sup>): 3041.74, 2924.09, 2854.65 (C-H stretching), 3309.85 (-NH-), 1633.71 (C=O stretching), 1485.19 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm):10.579 (s, 1H, HN-C=O), 4.489 (s, 1H, H-2a), 4.419 (d, 1H, H-4a), 3.437 (s, 1H, H-5e), 2.779 (d, 2H, H-7a and H-1e are merged together), 1.904 - 1.596 (m, 5H, H-8e, H-6a, H-8a, H-6e and ring NH), 1.447 (s, 1H, H-7e), 8.20 - 7.202 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 64.12 (C-2), 62.86 (C-4), 45.85 (C-1), 38.25 (C-5), 28.95 (C-8), 27.21 (C-6), 21.43 (C-7), 143.34 (C-2ʹ), 140.66 (C-4ʹ), 164.01 (C-9), 161.51 (HN-C=O), 140.30 - 126.42 (aromatic and thienoyl ring carbons).</p><p>2r, 4c-Bis (p-bromophenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 14</p><p>IR (KBr) (cm<sup>−1</sup>): 3039.81, 2966.52, 2922.16 and 2854.65 (C-H stretching), 3300.20 (-NH-), 1639.49 (C=O stretching), 1512.19 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.519 (s, 1H, HN-C=O), 4.465 (s, 1H, H-2a), 4.395 (s, 1H, H-4a), 3.471 (s, 1H, H-5e), 2.798 (m, 2H, H-7a, H-1e are merged together), 1.905 - 1.759 (m, 5H, H-8e, H-6a, H-8a, H-6e and ring NH are merged together), 1.441 (s, 1H, H-7e), 8.229 - 7.206 (m, 11H, aromatic and thienoyl ring protons).<sup> 13</sup>C NMR (δppm): 64.16 (C-2), 62.92 (C-4), 42.78 (C-1), 38.20 (C-5), 28.95 (C-8), 27.04 (C-6), 21.42 (C-7), 140.75 (C-2ʹ), 140.04 (C-4ʹ), 164.58 (C-9), 163.31 (HN-C=O), 134.80 - 121.23 (aromatic and thienoyl ring carbons).</p><p>2r, 4c-Bis (p-isopropylphenyl)-3-azabicyclo [3.3.1] nonan-9-one-2’-thienoyl hydrazone 15</p><p>IR (KBr) (cm<sup>−1</sup>): 3026.31, 2958.80, 2864.29, 2926.01 (C-H stretching), 3304.06 (-NH-), 1635.64 (C=O stretching), 1514.12 (&gt;C=N stretching), <sup>1</sup>H NMR (CDCl<sub>3</sub>, δppm): 10.625 (s, 1H, HN-C=O), 4.505 (s, 1H, H-2a), 4.419 (d, 1H, H-4a), 3.472 (s, 1H, H-5e), 2.990 (d, 3H, H-7a and p-isopropyl <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x16.png" xlink:type="simple"/></inline-formula> &amp;<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x17.png" xlink:type="simple"/></inline-formula>), 2.789 (s, 1H, H-1e), 1.977 (d, 2H, H-8e, H-6a), 1.716 - 1.594 (m, 3H, H-8a, H-6e and ring NH) 1.449 (d, 1H, H-7e), 1.337 (d,12H, p-isopropyl <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x18.png" xlink:type="simple"/></inline-formula>&amp; <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x19.png" xlink:type="simple"/></inline-formula> 8.229 - 7.182 (m, 11H, aromatic and thienoylring protons).<sup> 13</sup>C NMR (δppm): 64.69 (C-2), 63.40 (C-4). 46.15 (C-1), 38.59 (C-5), 28.70 (C-8), 27.06 (C-6), 21.61 (C-7), 148.19 (C-2ʹ), 147.95 (C-4ʹ), 163.84 (C-9) , 162.63 (HN-C=O), 24.19 - 23.86 (p-isopropyl<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x20.png" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x21.png" xlink:type="simple"/></inline-formula>,<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x21.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x23.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x21.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x23.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x22.png" xlink:type="simple"/></inline-formula>), 34.05 (p-isopropyl <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x21.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x23.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x22.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x24.png" xlink:type="simple"/></inline-formula><sup> </sup>&amp;<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x21.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x23.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x22.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x24.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x25.png" xlink:type="simple"/></inline-formula>), 139.96 - 126.23 (aromatic and thienoylring carbons).</p></sec></sec><sec id="s2_2"><title>2.2. Pharmacology</title><sec id="s2_2_1"><title>2.2.1. In Vitro Antioxidant Activity</title><p>The antioxidant capacity was measured by the 2, 2-Diphenyl-1-picrylhydrazyl (DPPH<sup>•</sup>) explained by Blois [<xref ref-type="bibr" rid="scirp.60062-ref21">21</xref>] . Hydroxyl radical (OH<sup>•</sup>) scavenging capacity was described by the method of Ren et al., (2008) [<xref ref-type="bibr" rid="scirp.60062-ref22">22</xref>] on the basis of the ability to complete with deoxyribose for OH<sup>•</sup>. Superoxide anions resulting from dissolved oxygen by a PMS/NADH coupling reaction reduced nitro blue tetrazolin (NBT) was evaluated by the procedure of Garrat et al. (1964) [<xref ref-type="bibr" rid="scirp.60062-ref23">23</xref>] . Scavenging capacity carried out triplicate of each sample and read at 515 nm using a micro plate reader (EL-800 Bio Tac instrument, Winoski, VT, USA). The percentage of scavenging assay DPPH<sup>•</sup>, OH<sup>•</sup> and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x26.png" xlink:type="simple"/></inline-formula> was calculated using the following formula</p><p>Free radical scavenging activity (%) = <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x27.png" xlink:type="simple"/></inline-formula></p><p>where Ac is the absorbance of control and As is absorbance of sample. BHT (Butylated hydroxytoluene) was used as standard drug. Which was calculated based on its concentration of compound required to reduce free radicals by 50% (IC<sub>50</sub>) as follows.</p></sec><sec id="s2_2_2"><title>2.2.2. Cell Culture and Preservation</title><p>Human liver cancer cell lines (HepG2) were obtained from the National centre for cell sciences (NCCS). Pune, India. The cells cultivated in 0.5 mg MTT (3, [4, 5-dimethythiazole-2-yl] 2, 5-diphenyl tetrazolium bromide)/ML. of serum free DMEM (Dulbecco’s modified Eagle’s medium) at 37˚C with 5% CO<sub>2</sub> and 95% air in a CO<sub>2</sub> incubator. The viability of cells was measured by MTT assay (Mosmann, 1983) [<xref ref-type="bibr" rid="scirp.60062-ref24">24</xref>] using the HepG2 cell lines. The cell lines were treated with various concentrations of test compounds (3.12, 6.25, 12.50, 25 and 50 &#181;g/mL) for 24 h. The 50% inhibitory concentration values (IC<sub>50</sub>) of all experiments of test compounds were done using three replicates. Cytotoxicity was detected by using Graph pad prism 5 software.</p></sec><sec id="s2_2_3"><title>2.2.3. Apoptosis Detection of Nuclear Morphology</title><p>Cells were stained with 0.5 mL of Hoechst 33342 solution (3.5 &#181;g/mL) and incubated for 30 min at 37˚C incubator. The Hoechst dyes can also be obtained from molecular probs. H342 is a “vital” DNA stain that binds preferentially to A-T base pains. Cells should be approximately 1.2 &#215; 10<sup>6</sup> mL in buffered media, pH 7.2. It is also useful to include 2 percent fetal half cell serum (FCS) to maintain the cell, and measured by fluorescence microscope at 490 - 520 nm [<xref ref-type="bibr" rid="scirp.60062-ref25">25</xref>] . Apoptotic cell were defined on the mass of nuclear morphology changes such as chromatin condensation and fragmentation. Early apoptotic cells show navy blue fluorescence.</p></sec><sec id="s2_2_4"><title>2.2.4. In Vitro Antibacterial and Antifungal Activity</title><p>Minimum inhibitory concentration (MIC) in &#181;g/mL values were found out by two-fold serial dilution method [<xref ref-type="bibr" rid="scirp.60062-ref26">26</xref>] . Bacterial strain namely Staphylococcus aureus. Escherichia coli, Klebsiella pheumoniae, pseudomonas aeruginosa and Salmonella typhi and fungal strain namely Cryptococcus neoformans, Candida albicans, Rizopus sp, Aspergillus nigar and Aspergillus flavus, were obtained from Faculty of medicine, Annamalai University, Annamalai Nagar, 608002, India. Seeded broth (broth containing microbial sporus) was prepared in NB from 24 hours old bacterial cultures on nutrient ager (Himedia, Mumbai) at 37˚C while fungal strains were cultures in sabourauds dextrose broth (SDB). Testing was performed at pH 7.4 &#177; 0.2 for bacteria (NB) and at a pH 5.6 for fungi (SDB). Plating techniques were used to determine the colony forming units (cfu) of the seeded broth in the adjusted range of 10<sup>4</sup> to 10<sup>5</sup> cfu/mL and 1.1 to 1.5 &#215; 10<sup>2</sup> cfu/mL were the final inoculums size for antibacterial and antifungal assay, respectively. The respective test compounds 9-15 were dissolved in dimethyl sulphoxide (DMSO) to obtain 1 mg/mL stock solution. The growth of the microbes in the test medium was measured on the turbidity of the culture after 24 hours of bacterial incubation and 72 - 96 hours of fungal incubation.</p></sec><sec id="s2_2_5"><title>2.2.5. Statistical Analysis<sup> </sup></title><p>All investigated data were presented as the percentage of Mean &#177; SEM (standard error of mean) of at least three individual experiments. Statistical analysis was performed with One-way ANOVA test analysis using the prism 5 statistical software package (graph pad software. USA). Differences were considered as being significant probability at p &lt; 0.005.<sup> </sup></p></sec></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Chemistry</title><p>The structural elucidation and stereochemistry of target compounds 9-15 were assigned by IR and NMR spectral data. Their purities were checked by elemental analysis <xref ref-type="table" rid="table1">Table 1</xref>. For compound 9, proton NMR <sup>1</sup>H and<sup>13</sup>C NMR signal were assigned unambiguously using two-dimensional spectra.</p></sec><sec id="s3_2"><title>3.2. Numbering of Atoms</title><p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows the numbering pattern of the bicyclo [3.3.1] nonane part. The ipso carbons of the phenyl rings at C-2 and C-4 are designated as C-2&quot; and C-4&quot;, respectively. The other carbons of the phenyl ring at C-2 are denoted also o, m and p carbons and those of the phenyl ring at C-4 were denoted as oʹ, mʹ, pʹ, carbons. Protons are numbered accordingly. Thiophene ring sulpfur atom was denoted as 1’. For illustrated, the benzyl proton at C-2 was denoted as H-2, C-4 was denoted as H-4 and so on. The methylene protons in the cyclohexane ring are</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Elemental analytical data of titled compound 9-15</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Comp ound</th><th align="center" valign="middle"  rowspan="2"  >Molecular Formula</th><th align="center" valign="middle"  rowspan="2"  >Molecular weight</th><th align="center" valign="middle"  rowspan="2"  >Melting Point ˚C</th><th align="center" valign="middle"  rowspan="2"  >Yield %</th><th align="center" valign="middle"  colspan="4"  >Elemental analysis found<sup>*</sup> (calculated) in %</th></tr></thead><tr><td align="center" valign="middle" >C</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >N</td><td align="center" valign="middle" >S</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>OS</td><td align="center" valign="middle" >415.55</td><td align="center" valign="middle" >216</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >72.52 (72.26)</td><td align="center" valign="middle" >6.32 (6.06)</td><td align="center" valign="middle" >10.42 (10.11)</td><td align="center" valign="middle" >7.52 (7.72)</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>OS</td><td align="center" valign="middle" >443.60</td><td align="center" valign="middle" >220</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >73.35 (73.10)</td><td align="center" valign="middle" >6.34 (6.59)</td><td align="center" valign="middle" >9.68 (9.47)</td><td align="center" valign="middle" >7.43 (7.23)</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>3</sub>S</td><td align="center" valign="middle" >475.60</td><td align="center" valign="middle" >204</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >68.37 (68.18)</td><td align="center" valign="middle" >6.21 (6.15)</td><td align="center" valign="middle" >8.76 (8.84)</td><td align="center" valign="middle" >6.58 (6.74)</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >C<sub>25</sub>H<sub>23 </sub>F<sub>2</sub>N<sub>3</sub>OS</td><td align="center" valign="middle" >451.53</td><td align="center" valign="middle" >224</td><td align="center" valign="middle" >78</td><td align="center" valign="middle" >66.56 (66.50)</td><td align="center" valign="middle" >5.32 (5.13)</td><td align="center" valign="middle" >9.33 (9.31)</td><td align="center" valign="middle" >7.47 (7.10)</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >C<sub>25</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>3</sub>OS</td><td align="center" valign="middle" >484.44</td><td align="center" valign="middle" >210</td><td align="center" valign="middle" >81</td><td align="center" valign="middle" >61.69 (61.98)</td><td align="center" valign="middle" >4.58 (4.79)</td><td align="center" valign="middle" >8.57 (8.67)</td><td align="center" valign="middle" >6.59 (6.62)</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >C<sub>25</sub>H<sub>23</sub>Br<sub>2</sub>N<sub>3</sub>OS</td><td align="center" valign="middle" >573.34</td><td align="center" valign="middle" >217</td><td align="center" valign="middle" >82</td><td align="center" valign="middle" >52.34 (52.37)</td><td align="center" valign="middle" >4.28 (4.04)</td><td align="center" valign="middle" >7.36 (7.33)</td><td align="center" valign="middle" >5.89 (5.59)</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >C<sub>31</sub>H<sub>37</sub>N<sub>3</sub>OS</td><td align="center" valign="middle" >499.71</td><td align="center" valign="middle" >209</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >74.56 (74.51)</td><td align="center" valign="middle" >7.32 (7.46)</td><td align="center" valign="middle" >8.77 (8.41)</td><td align="center" valign="middle" >6.37 (6.42)</td></tr></tbody></table></table-wrap><p><sup>*</sup>The measured values for C, H, N and S were within &#177;0.4% of the theoretical values.</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Numbering of the atoms</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x28.png"/></fig><p>assigned as axial and equatorial protons assuming chair conformation for the cyclohexanone ring. C-7 protons are denoted as H-7a and H-7e.</p></sec><sec id="s3_3"><title>3.3. IR Spectral Analysis</title><p>Hydrazones formation were assigned by C=N stretching frequency at present in the range of 1485 - 1516 cm<sup>−1</sup>. The bicyclic NH stretching frequency was in the range 3300 - 3309 cm<sup>−1</sup> and the amide (C=O) stretching frequency was in the range 1633 - 1641 cm<sup>−1</sup>. The amide NH stretching frequency was in the range 3024 - 3163 cm<sup>−1</sup>, the adsorption band in the region of 2845 - 3041 cm<sup>−1</sup> were attributed to aromatic, thienoyl ring and aliphatic C-H stretching frequencies [<xref ref-type="bibr" rid="scirp.60062-ref8">8</xref>] .</p></sec><sec id="s3_4"><title>3.4. <sup>1</sup>H NMR Spectral Analysis</title><p>For compound 9 the <sup>1</sup>H NMR signals were unambiguously assigned based on the observed correlation in the two dimensional (2D) NMR spectra. A broad and down field singlet at 10.21 ppm was characteristic of the NH amide group. Signal broadening is due to the faster exchange of NH proton with solvent moisture than the resonance time scale. NH proton of the bicyclic ring and H-8a &amp; H-6e protons were merged together and appeared as multiplets at 1.59 ppm. However, signal that appeared at 2.76 and 3.34 ppm should be due to its bridgehead protons H-1e and H-5e, respectively. Two signals appeared at 4.49 and 4.39 ppm corresponds to each one proton integral. Furthermore, these two signal strong NOE shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>, with doublet at 7.64 ppm and singlet at 2.76 &amp; 3.34 ppm. Hence unambiguity, these two signals are attributed to benzylic protons H-2a and H-4a. However, peaks at 2.76 and 3.34 ppm have been weak COSY correlation <xref ref-type="fig" rid="fig3">Figure 3</xref> with benzylic protons and strong correlation with H-6a (1.88 ppm) and H-8a (1.59 ppm). H-1e and H-5e signal, one was highly deshielded</p><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> NOESY Spectrum of compound 9</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x29.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> <sup>1</sup>H-<sup>1</sup>H COSY and NOESY correlations of compound 9</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x30.png"/></fig><p>due to special interaction between the nitrogen (&gt;CONH-) of thienoyl hydrazone analogue and one of the bridgehead proton. Outstanding to this interaction, partial charges created between them [<xref ref-type="bibr" rid="scirp.60062-ref27">27</xref>] . As a result, the bridge head α-carbon acquires slight negative (-ve) charge and the attached proton gets slight (+ve) charge as shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>. From this, the deshielded signal can be unambiguously assigned to syn α(H-5) bridgehead proton whereas shielded signal was assigned to anti α(H-1) proton.</p><p>Among the two observed signal 1.59 ppm and 1.88 ppm were deshielded signal assigned to H-6e and H-8e protons and the shielded one was assigned to H-6a and H-8a protons. Furthermore, the signals for C-7 protons were magnetically nonequivalent and observed at 2.87 and 1.41 ppm respectively for H-7a and H7e. H-7a proton were deshielded due to deshieding creates vanderwaals interaction. Therefore H-7a proton was highly deshielded than H-7e proton <sup>1</sup>H-<sup>1</sup>H COSY correlation chemical shift of compound 9 shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, H-2 and H-4 proton have also shown a cross peak with doublet at 7.64 ppm which suggest that the signal have four protons integral is due to ortho protons of phenyl ring. All the aromatic and thienoyl ring protons which were collectively resonate between 7.13 to 8.16 ppm. All these surveillance were consistent with twin-chair (CC) conformation for this compound 9. For all other target compounds the <sup>1</sup>H signal were assigned by comparison with compound 9.</p></sec><sec id="s3_5"><title>3.5. <sup>13</sup>C NMR Spectral Analysis</title><p>In <sup>13</sup>C NMR spectral of synthesized compound 9, two downfield signals 163.56 and 161.81 ppm were assigned for C=N and C=O carbons, respectively. However, there were two resonance carbon signals at 65.47 and 63.60 ppm is respectively due to C-2 and C-4 carbons. Furthermore, the carbon concerned in the fusion part C-5 and C-1 were consigned from the downfield signal at 38.41 and 46.09 ppm, respectively. The methylene carbons signal C-6, C-7 and C-8 of cyclohexanone were assigned in the region of 27.34, 21.56, and 28.56 ppm, respectively. Aromatic, ipso and thienoyl hydrazone carbons were assigned with admiration to their <sup>1</sup>H-<sup>13</sup>C COSY (HSQC) correlations shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>. Assignments for the other synthesized compounds 10-15 were made by comparison with compound 9. X-ray crystallographic study established that 2r, 4c-diphenyl-9t-ethynyl-3-aza- bicyclo [3.3.1] nonan-9t-ol exists in twin chair conformation with equatorial orientations of the aryl groups [<xref ref-type="bibr" rid="scirp.60062-ref28">28</xref>] .</p><fig id="fig4"  position="float"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Non-bonded interaction between H-5e and nitrogen (thienoyl hydrazone NHCO)</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x31.png"/></fig><fig id="fig5"  position="float"><label><xref ref-type="fig" rid="fig5">Figure 5</xref></label><caption><title> <sup>1</sup>H-<sup>1</sup>H COSY Spectrum of compound 9</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x32.png"/></fig><fig id="fig6"  position="float"><label><xref ref-type="fig" rid="fig6">Figure 6</xref></label><caption><title> HSQC Spectrum of compound 9</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x33.png"/></fig><p>Taken together, all of the above observations substantiate planned structure and twin-chair (CC) conformation of 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-one-2-thienoyl hydrazones (9-15).</p></sec><sec id="s3_6"><title>3.6. In Vitro Free Radical Scavenging Activity</title><p>Seven various 2-thienoyl hydrazone derivatives 9-15 were examined for their in vitro antioxidant activity against DPPH<sup>•</sup>, OH<sup>•</sup> and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x34.png" xlink:type="simple"/></inline-formula> radicals. 50 percent (50%) inhibitory concentration (IC<sub>50</sub>) values for the free radical scavenging effect of BHT and various substituted synthetic compounds 9-15 were shown in <xref ref-type="table" rid="table2">Table 2</xref>. Free radical scavenging activity was treated with different concentration level 3.12, 6.25, 12.5, 25 and 50 &#181;g/mL. We reported that electron-donor methoxy (OCH<sub>3</sub>) substitution compound 11 (IC<sub>50</sub> range 3.78 - 4.31 &#181;g/mL) showed excellent antioxidant capacity compared to other compounds and standard antioxidant, a known antioxidant used as a positive control shown in <xref ref-type="fig" rid="fig7">Figure 7</xref>. Tested with compound 9 devoid of any substituent at phenyl ring at C-2 and C-4 positions of the azabicyclo [3.3.1] nonan-9-one inhibited 50% of the different free radicals at the concentration range 34.26 - 35.65 &#181;g/mL. Compound possessing electron withdrawing fluoro, chloro and bromo substitutions at the phenyl rings showed admirable in-vitro free radical scavenging effect against DPPH<sup>•</sup>, OH<sup>•</sup> and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x34.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x35.png" xlink:type="simple"/></inline-formula> radicals. Therefore, antioxidant capacity of all the synthesized compounds were in the decreasing order 11 &gt; 15 &gt; 10 &gt; 9 &gt; 14 &gt; 13 &gt; 12.</p></sec><sec id="s3_7"><title>3.7. In Vitro Anticancer Activity</title><p>Human liver cancers foremost reason for human death and malignancy throughout the world, according to survey 7.6 million death in 2010 century and anticipated to reach the figure of almost 13 million death by 2030 century, about 70% cancers [<xref ref-type="bibr" rid="scirp.60062-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.60062-ref30">30</xref>] . The aim of present work challenged cytotoxic activity against on a panel of human liver hapatocellular carcinoma (HepG2) [<xref ref-type="bibr" rid="scirp.60062-ref31">31</xref>] was treated with the innovative target compound 9-15 significantly inhibited the proliferation of cancer cell lines in various concentrations manner (3.12, 6.25, 12.5, 25</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Inhibitory concentration values (IC<sub>50</sub>) for anti-oxidant activity of compound 9-15</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Compound</th><th align="center" valign="middle"  rowspan="2"  >R</th><th align="center" valign="middle"  colspan="3"  >IC<sub>50</sub> values for free radical scavenging activity(&#181;g/mL)</th></tr></thead><tr><td align="center" valign="middle" >DPPH<sup>•</sup></td><td align="center" valign="middle" >OH<sup>•</sup></td><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1790084x36.png" xlink:type="simple"/></inline-formula></td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >H</td><td align="center" valign="middle" >35.23 &#177; 0.083</td><td align="center" valign="middle" >35.65 &#177; 0.056</td><td align="center" valign="middle" >34.26 &#177; 0.010</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >p-CH<sub>3</sub></td><td align="center" valign="middle" >8.09 &#177; 0.074</td><td align="center" valign="middle" >7.56 &#177; 0.012</td><td align="center" valign="middle" >8.49 &#177; 0.098</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >p-OCH<sub>3</sub></td><td align="center" valign="middle" >3.78 &#177; 0.056</td><td align="center" valign="middle" >4.31 &#177; 0.063</td><td align="center" valign="middle" >4.23 &#177; 0.063</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >p-F</td><td align="center" valign="middle" >41.44 &#177; 0.053</td><td align="center" valign="middle" >40.46 &#177; 0.098</td><td align="center" valign="middle" >40.26 &#177; 0.057</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >p-Cl</td><td align="center" valign="middle" >37.92 &#177; 0.077</td><td align="center" valign="middle" >38.59 &#177; 0.0925</td><td align="center" valign="middle" >37.95 &#177; 0.090</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >p-Br</td><td align="center" valign="middle" >35.01 &#177; 0.084</td><td align="center" valign="middle" >37.93 &#177; 0.035</td><td align="center" valign="middle" >36.97 &#177; 0.091</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >p-CH(CH<sub>3</sub>)<sub>2</sub></td><td align="center" valign="middle" >4.61 &#177; 0.071</td><td align="center" valign="middle" >4.59 &#177; 0.039</td><td align="center" valign="middle" >5.16 &#177; 0.093</td></tr><tr><td align="center" valign="middle" >BHT</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" >5.46 &#177; 0.064</td><td align="center" valign="middle" >5.66 &#177; 0.013</td><td align="center" valign="middle" >5.86 &#177; 0.011</td></tr></tbody></table></table-wrap><fig id="fig7"  position="float"><label><xref ref-type="fig" rid="fig7">Figure 7</xref></label><caption><title> Antioxidant activity of standard (BHT) drug and synthesized compounds 9-15</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x37.png"/></fig><p>and 50 &#181;g/mL.), after 24 hours of incubation were examined by means of the MTT assay. IC<sub>50</sub> values for the cytotoxic effect of synthetic compounds were shown in <xref ref-type="table" rid="table3">Table 3</xref>. The incorporation of electron withdrawing group such as F, Cl and Br substitution at para position of C-2, C-4 diaryl rings of the 3-azabycyclo [3.3.1] nonan-9-one compounds 12, 13 and 14 exhibit more cytotoxicity than electron donating group such as CH<sub>3</sub>, OCH<sub>3</sub> and CH (CH<sub>3</sub>)<sub>2</sub> substitution at para position of C-2, C-4 diaryl rings of the 3-azabycyclo [3.3.1] nonan-9-one compounds 10, 11 and 15. Especially the compound 12 (IC<sub>50</sub> = 3.76 &#181;g/mL) shows excellent cytotoxicity than compounds 13 and 14. We found the strong cytotoxicity with poor antioxidant property of synthesized compounds 12, 13 and 14 may be due to the pro-oxidant effect by halogens [<xref ref-type="bibr" rid="scirp.60062-ref11">11</xref>] . The overall cytotoxicity effect of synthesized compounds were in the decreasing order 12 &gt; 13 &gt; 14 &gt; 11 &gt; 15 &gt; 10 &gt; 9. However several mechanisms regulating the antioxidant and anticancer activity of hybrid molecule are needed for advance research.</p></sec><sec id="s3_8"><title>3.8. Discovery of Apoptosis by Hoechst Staining</title><p>In treated and controlled cells, apoptosis in nuclear morphology by using Hoechst 33342 (H342) were experiential and compared in the <xref ref-type="fig" rid="fig8">Figure 8</xref>. Fluorescence microscopy analysis was used to assess the apoptotic feature in HepG2 cancer cells induced by fluoro substituted compound 12. The control showed normal health and whole nuclei without any cytomorphological abnormalities. The HepG2 cell lines were treated with 50% inhibitory</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Anticancer activity of target compounds (9-15) against human liver hepatocellular carcinoma cell lines (HepG2)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="3"  >Compound</th><th align="center" valign="middle"  colspan="5"  >Compound concentrations (&#181;g/mL)</th><th align="center" valign="middle"  rowspan="3"  >Ic<sub>50</sub> values (&#181;g/mL)</th></tr></thead><tr><td align="center" valign="middle" >3.12</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >12.50</td><td align="center" valign="middle" >25.00</td><td align="center" valign="middle" >50.00</td></tr><tr><td align="center" valign="middle"  colspan="5"  >Death cells (% of Mean &#177; SE)<sup>b</sup><sup> </sup></td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >5.371 &#177; 0.029</td><td align="center" valign="middle" >12.320 &#177; 0.057</td><td align="center" valign="middle" >20.595 &#177; 0.042</td><td align="center" valign="middle" >31.372 &#177; 0.044</td><td align="center" valign="middle" >57.291 &#177; 0.024</td><td align="center" valign="middle" >42.49</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >12.277 &#177; 0.035</td><td align="center" valign="middle" >25.319 &#177; 0.015</td><td align="center" valign="middle" >34.144 &#177; 0.041</td><td align="center" valign="middle" >46.320 &#177; 0.029</td><td align="center" valign="middle" >81.963 &#177; 0.023</td><td align="center" valign="middle" >26.26</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >21.275 &#177; 0.042</td><td align="center" valign="middle" >39.513 &#177; 0.081</td><td align="center" valign="middle" >48.544 &#177; 0.037</td><td align="center" valign="middle" >80.648 &#177; 0.038</td><td align="center" valign="middle" >97.286 &#177; 0.068</td><td align="center" valign="middle" >12.92</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >39.312 &#177; 0.044</td><td align="center" valign="middle" >69.759 &#177; 0.023</td><td align="center" valign="middle" >84.536 &#177; 0.002</td><td align="center" valign="middle" >98.365 &#177; 0.013</td><td align="center" valign="middle" >&gt;100</td><td align="center" valign="middle" >3.76</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >28.202 &#177; 0.026</td><td align="center" valign="middle" >47.343 &#177; 0.060</td><td align="center" valign="middle" >79.348 &#177; 0.025</td><td align="center" valign="middle" >89.341 &#177; 0.015</td><td align="center" valign="middle" >98.114 &#177; 0.014</td><td align="center" valign="middle" >6.94</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >25.382 &#177; 0.049</td><td align="center" valign="middle" >41.325 &#177; 0.012</td><td align="center" valign="middle" >79.105 &#177; 0.073</td><td align="center" valign="middle" >89.405 &#177; 0.100</td><td align="center" valign="middle" >98.103 &#177; 0.004</td><td align="center" valign="middle" >8.10</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >14.196 &#177; 0.033</td><td align="center" valign="middle" >25.347 &#177; 0.063</td><td align="center" valign="middle" >39.173 &#177; 0.018</td><td align="center" valign="middle" >78.252 &#177; 0.014</td><td align="center" valign="middle" >93.235 &#177; 0.017</td><td align="center" valign="middle" >17.52</td></tr></tbody></table></table-wrap><p><sup>b</sup>Values are expressed as the mean &#177; SE (standard error) from at least three independent experiments. IC<sub>50</sub>: Compound concentration required to inhibit cancer cells proliferation by 50%.</p><fig id="fig8"  position="float"><label><xref ref-type="fig" rid="fig8">Figure 8</xref></label><caption><title> The effect of fluorescent microscope image of (a) control (b) the cell treated HepG2 cell lines with IC<sub>50</sub> concentration 3.76 &#181;g/mL of the most active lead compound 12. Stained with Hoechst 33342 (H342). These cell lines detected by 490 - 520 nm of fluorescent microscope excitation/emission</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1790084x38.png"/></fig><p>concentration among the efficient cytotoxic compound 12 and IC<sub>50</sub> value is 3.76 &#181;g/mL for 48 hours. The dark blue (navy blue) fluorescence indicated the viable cells while the bluish white fluorescence indicated the death cells. The above results of 490 - 520 nm of fluorescence microscopy using Hoechst stain control <xref ref-type="fig" rid="fig8">Figure 8</xref>(a) and treated HepG2 cell lines <xref ref-type="fig" rid="fig8">Figure 8</xref>(b). Bright condensed chromatin (pyknosis) and cell shrinkage was observed in these compound treated apoptotic cells. The report of the procedure, disintegration of the nucleus was also observed in the treated cell lines.</p></sec><sec id="s3_9"><title>3.9. In Vitro Antimicrobial Activity</title><p>The in vitro antibacterial activity of synthesized compounds 9-15 were treated with bacterial strains viz., (S. aureus. E. coli, K. pheumoniae, p. aeruginosa and S. typhi) and were expressed as minimum inhibitory concentrations (MIC) in &#181;g/mL. Streptomycin was taken as standard drug [<xref ref-type="bibr" rid="scirp.60062-ref32">32</xref>] and the observed MIC values were given in <xref ref-type="table" rid="table4">Table 4</xref> Compound 12, 13 and 14 possessing para halo substitution at phenyl rings of azabicyclononane derivatives account for the superior inhibitory effect against S. aureus, K. pheumoniae and S. typhi at MIC values of 6.25 &#181;g/mL, and p. aeruginosa at MIC values of 12.50 &#181;g/mL when compared to standard antibiotic streptomycin. Evidenced that electron withdrawing group substituted azabicyclononane derivatives exhibited marvelous antimicrobial activities [<xref ref-type="bibr" rid="scirp.60062-ref33">33</xref>] . Other target compound displayed reduced inhibitory effect against different bacterial strains compared to standard drug. The account of the present study also provide proof for the antifungal</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> In vitro antimicrobial screening of target compounds 9-15</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Compounds</th><th align="center" valign="middle"  colspan="5"  >Bacterial strains Minimum inhibitory concentration (MIC) in &#181;g/mL</th><th align="center" valign="middle"  colspan="5"  >Fungal strains Minimum inhibitory concentration (MIC) in &#181;g/mL</th></tr></thead><tr><td align="center" valign="middle" >S. aureus</td><td align="center" valign="middle" >E. coli</td><td align="center" valign="middle" >K. pheumoniae</td><td align="center" valign="middle" >P.aeruginosa</td><td align="center" valign="middle" >S. typhi</td><td align="center" valign="middle" >C. albicans</td><td align="center" valign="middle" >C. neoformans</td><td align="center" valign="middle" >Rizopus. sp</td><td align="center" valign="middle" >A nigar</td><td align="center" valign="middle" >A. flavus</td></tr><tr><td align="center" valign="middle" >9</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >50</td></tr><tr><td align="center" valign="middle" >10</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >50</td></tr><tr><td align="center" valign="middle" >11</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >12</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >13</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >14</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >6.25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td></tr><tr><td align="center" valign="middle" >15</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Standard<sup>* </sup></td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >12.5</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td><td align="center" valign="middle" >25</td></tr></tbody></table></table-wrap><p><sup>*</sup>Standard drug used: for antibacterial activity―Streptomycin, for antifungal activity―Amphotericin B.</p><p>effect of an array of 2-thienoyl hydrazones 9-15 with MIC values shown in the <xref ref-type="table" rid="table4">Table 4</xref>. Compound 12, 13 and 14 had enhanced inhibitory effect against all tested fungi strains and standard drug (Amphotericin B) of MIC range was 6.25 - 12.5 &#181;g/mL, and isopropyl substituted compound 15 exhibited identical potency compared to standard drug except C. neoformans strain. Other compounds exhibited mild inhibitory potency against different fungi strains compared to standard drug.</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>The report of the present study of 2-thienoyl hydrazones of 2r, 4c-diaryl-3-azabicyclo [3.3.1] nonan-9-ones in excellent yield, stereochemistry and characterized by elemental analysis and spectral data 1D and 2D NMR spectra. All of the above observations substantiate the proposed structure and twin-chair (CC) conformation of all target compounds 9-15. The compounds were evaluated various biological activities. Through the target compound with electron withdrawing such as F, Cl, Br substitution compounds were superior anticancer, antibacterial and antifungal activity. However, the electron donating substituted such as CH<sub>3</sub>, OCH<sub>3</sub> and CH(CH<sub>3</sub>)<sub>2</sub> compounds act great antioxidant activity than electron withdrawing substituted compounds. Studies on the structural mechanisms by which the new synthetic molecules put forth its anticancer, antioxidant, antibacterial and antifungal activity are making development and will be delivered in the prospect.</p></sec><sec id="s5"><title>Acknowledgements</title><p>The authors were great thankful to The Department of Chemistry, Annamalai University, Tamilnadu, India, for the recording of the NMR spectral data’s and providing all necessary facilities to found the present work successfully. We extend our gratitude to the RMMCH, Annamalai University for biological studies.</p></sec><sec id="s6"><title>Cite this paper</title><p>M.Manimaran,A.Ganapathi,T.Balasankar, (2015) Synthesis, Spectral, Anti-Liver Cancer and Free Radical Scavenging Activity of New Azabicyclic Thienoyl Hydrazone Derivatives. Open Journal of Medicinal Chemistry,05,33-47. doi: 10.4236/ojmc.2015.53004</p></sec><sec id="s7"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.60062-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">(2013) Cancer. Fact Sheet No. 297, World Health Organization, Geneva.  
http://www.who.int/mediacentre/factsheets/fs297/en/.</mixed-citation></ref><ref id="scirp.60062-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Poljsak, B., Suput, D. and Milisav, I. (2013) Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants. Oxidative Medicine and Cellular Longevity, 2013, Article ID: 956792.  
http://dx.doi.org/10.1155/2013/956792</mixed-citation></ref><ref id="scirp.60062-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Valko, M., Leibfritz, D., Moncol, J., et al. (2007) Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease. International Journal of Biochemistry &amp; Cell Biology, 39, 44-84.  
http://dx.doi.org/10.1016/j.biocel.2006.07.001</mixed-citation></ref><ref id="scirp.60062-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kasai, H. and Kawai, K. (2006) Oxidative DNA Damage: Mechanisms and Significance in Health and Disease. Antioxidants &amp; Redox Signaling, 8, 981-983. http://dx.doi.org/10.1089/ars.2006.8.981</mixed-citation></ref><ref id="scirp.60062-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Jayaraman, P. and Avila, S. (1981) Chemistry of 3-Azabicyclo [3.3.1] Nonanes. Chemical Reviews, 81, 149-174.  
http://dx.doi.org/10.1021/cr00042a002</mixed-citation></ref><ref id="scirp.60062-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Hardick, D.I., Balagbrough, I.S., Cooper, G., Potter, B.V.L., Critchley, T. and Wonnacott, S. (1996) Nudicauline and Elatine as Potent Norditerpenoid Ligands at Rat Neuronal a-Bungarotoxin Binding Sites: Importance of the 2-(Methyl- succinimido)benzoyl Moiety for Neuronal Nicotinic Acetylcholine Receptor Binding. Journal of Medicinal Chemistry, 39, 4860-4866. http://dx.doi.org/10.1021/jm9604991</mixed-citation></ref><ref id="scirp.60062-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Barker, D., Lin, D.H.S., Crland, J.E., Chu, C.P.Y., Chebib, M., Brimble, M.A., Savage, C.P. and Mclead, M.D. (2005) Methyllycaconitine Analogues Have Mixed Antagonist Effects at Nicotinic Acetylcholine Receptors. Bioorganic &amp; Medicinal Chemistry, 13, 4565-4575. http://dx.doi.org/10.1016/j.bmc.2005.04.054</mixed-citation></ref><ref id="scirp.60062-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sankar, C. and Pandiarajan, K. (2010) Synthesis and Anti-Tubercular and Antimicrobial Activities of Some 2r, 4c-diaryl- 3-azabicyclo[3.3.1] Nonan-9-One N-Isonicotinoylhydrazone Derivatives. European Journal of Medicinal Chemistry, 46, 5480-5485. http://dx.doi.org/10.1016/j.ejmech.2010.08.024</mixed-citation></ref><ref id="scirp.60062-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ramachandran, R., Rani, M. and Kabilan, S. (2010) Synthesis, Structure and Conformational Analysis of 2,4-Diaryl-3- Azabicyclo[3.3.1]nonan-9-One Thiosemicarbazones and Semicarbazones. Journal of Molecular Structure, 970, 42-50.  
http://dx.doi.org/10.1016/j.molstruc.2010.02.005</mixed-citation></ref><ref id="scirp.60062-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Khaledi, H., Alhadi, A.A., Yehye, W.A., Ali, H.M., Abdulla, M.A. and Hassandarvish, P. (2011) Antioxidant, Cytotoxic Activities, and Structure-Activity Relationship of Gallic Acid-Based Indole Derivatives. Archiv der Pharmazie, 344, 703-709. http://dx.doi.org/10.1002/ardp.201000223</mixed-citation></ref><ref id="scirp.60062-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Lee, C.Y., Sharma, A., Uzarski, R.L., Cheong, J.E., Xu, H., Held, R.A., Upadhaya, S.K. and Nelson, J.L. (2011) Potent Antioxidant Dendrimers Lacking Pro-Oxidant Activity. Free Radical Biology and Medicine, 50, 918-925.  
http://dx.doi.org/10.1016/j.freeradbiomed.2010.10.699</mixed-citation></ref><ref id="scirp.60062-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Chitra, S., Devanathan, D. and Pandiarajan, K. (2010) Synthesis and in Vitro Microbiological Evaluation of Novel 4-Aryl-5-Isopropoxycarbonyl-6-Methyl-3,4-Dihydropyrimidinones. European Journal of Medicinal Chemistry, 45, 367-371. http://dx.doi.org/10.1016/j.ejmech.2009.09.018</mixed-citation></ref><ref id="scirp.60062-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Rossi, C., Figini, A. and Corpi, A. (1968) Antiarrhythmic Action of Certain 1,5-Diphenyl-Bispidin Derivatives. Annali dell’Istituto Superiore di Sanità, 4, 333. (1969) Chemical Abstracts Service, 70, 85997s.</mixed-citation></ref><ref id="scirp.60062-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Chivarelli, S., Delcarmine, R. and Michalek, H. (1972) Effect of Some Antiarrhythmic 1,5-Diphenyl-Bispidine Derivatives on in Vitro Oxygen Uptake and Glucose Utilization of Rat Heart Muscle. Annali dell’Istituto Superiore di Sanità, 8, 156. (1973) Chemical Abstracts Service, 78, 24098z.</mixed-citation></ref><ref id="scirp.60062-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Binning, F., Friedrich, L., Hofmann, H.P., Kreiskoh, H., Raschack, M. and Muller, C. (1978) Neue Bispidinderivate, verfahren Zu deren Herstellung und Arzneimittel, Welche diese enthalten. German Patent No. 2726571. (1979) Chemical Abstracts Service, 90, 121568h.</mixed-citation></ref><ref id="scirp.60062-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">a) Ganellin, C.R. and Spickett, R.G.W. (1965) Compounds Affecting the Central Nervous System. I. 4-Piperidones and Related Compounds. Journal of Medicinal Chemistry, 8, 619-625. http://dx.doi.org/10.1021/jm00329a015 
b) El-Subbagh, H.I., Abu-Zaid, S.M., Mahran, M.A., Badria, F.A. and Al-obaid, A.M. (2000) Synthesis and Biological Evaluation of Certain α,β-Unsaturated Ketones and Their Corresponding Fused Pyridines as Antiviral and Cytotoxic Agents. Journal of Medicinal Chemistry, 43, 2915-2921. http://dx.doi.org/10.1021/jm000038m</mixed-citation></ref><ref id="scirp.60062-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Olayinka, O.A., Craig, A.O., Obinna, C.N. and David, A.A. (2010) Microwave Assisted Synthesis and Antimicrobial Activity of 2-Quinoxalinone-3-Hydrazone Derivatives. Bioorganic &amp; Medicinal Chemistry, 18, 214-221.  
http://dx.doi.org/10.1016/j.bmc.2009.10.064</mixed-citation></ref><ref id="scirp.60062-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Fang, V.S., Minkin, C. and Goldhaber, P. (1971) 2-Thiophenecarboxylic Acid: Inhibitor of Bone Resorption in Tissue Culture. Science, 172, 163-165. http://dx.doi.org/10.1126/science.172.3979.163</mixed-citation></ref><ref id="scirp.60062-ref19"><label>19</label><mixed-citation publication-type="book" xlink:type="simple">Pratt, J.W. (2003) In: Wiley-VCH, Ed., Ullmann’s Encyclopedia of Industrial Chemistry, Vol. 36, Wiley-VCH, Weinheim, 653.</mixed-citation></ref><ref id="scirp.60062-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Baliah, V. and Jeyaraman, R. (1971) Synthesis of Some 3-Azabicyclo[3.3.1]Nonan-9-One. Indian Journal of Chemistry, 9, 1020-2022.</mixed-citation></ref><ref id="scirp.60062-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Blois, M.S. (1958) Antioxidant Determinations by the Use of a Stable Free Radical. Nature, 26, 1199-1200.  
http://dx.doi.org/10.1038/1811199a0</mixed-citation></ref><ref id="scirp.60062-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ren, J.Y., Zhao, M.M., Shi, J., Wang, J.S., Jiang, Y.M., Cui, C., et al. (2008) Purification and Identification of Antioxidant Peptides from Grass Carp Muscle Hydrolysates by Consecutive Chromatography and Electrospray Ionization-Mass Spectrometry. Food Chemistry, 108, 727-736. http://dx.doi.org/10.1016/j.foodchem.2007.11.010</mixed-citation></ref><ref id="scirp.60062-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Garratt, C.J. (1964) Effect of Iodination on the Biological Activity of Insulin. Nature, 201, 1324-1325.  
http://dx.doi.org/10.1038/2011324a0</mixed-citation></ref><ref id="scirp.60062-ref24"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mosmann</surname><given-names> T. </given-names></name>,<etal>et al</etal>. (<year>1983</year>)<article-title>Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays</article-title><source> Journal of Immunological Methods</source><volume> 65</volume>,<fpage> 55</fpage>-<lpage>63</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.60062-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Standar, A., Marais, S., Stivaktas, V., Vorster, C., Albrecht, C., Lottering, M.-L. and Joubert, A.M. (2009) In Vitro Effects of Sutherlandia frutescens Water Extracts on Cell Numbers, Morphology, Cell Cycle Progression and Cell Death in a Tumorigenic and a Non-Tumorigenic Epithelial Breast Cell Line. Journal of Ethnopharmacology, 124, 45-60.  
http://dx.doi.org/10.1016/j.jep.2009.04.013</mixed-citation></ref><ref id="scirp.60062-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Dhar, M.H., Dhar, M.M., Dhawan, B.N., Mahrora, B.N. and Ray, C. (1968) Screening of Indian Plants for Biological Activity: I. Indian Journal of Experimental Biology, 6, 232-247.</mixed-citation></ref><ref id="scirp.60062-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Sylvestre, S. and Pandiarajan, K. (2011) NMR Spectral Study of Some2r,6c-Diarylpiperidine-4-One (3’-Hydroxy-2’- Napthoyl)Hydrazones with Special Reference to γ-Syn Effect. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 78, 153-159. http://dx.doi.org/10.1016/j.saa.2010.09.015</mixed-citation></ref><ref id="scirp.60062-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Gladii, Y.P., Omarov, T.T. and Buranbaev, M.Z. (1993) X-Ray Diffraction Study of 2,4-Diphenyl-9-Ethynyl-3-Aza- bicyclo-[3.3.1]Nonan-9-Ol. Journal of Structural Chemistry, 34, 336-338. http://dx.doi.org/10.1007/BF00761492</mixed-citation></ref><ref id="scirp.60062-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">WHO (World Health Organization) (2008) World Cancer Report. 1-26.</mixed-citation></ref><ref id="scirp.60062-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Bray, F., Jemal, A., Grey, N., Ferlayand, J. and Forman, D. (2012) Global Cancer Transitions According to the Human Development Index (2008-2030): A Population-Based Study. Lancet Oncology, 13, 790-801.  
http://dx.doi.org/10.1016/S1470-2045(12)70211-5</mixed-citation></ref><ref id="scirp.60062-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Hosono, S., Lee, C.S., Chou, M.J., Yang, C.S. and Shih, C.H. (1999) Molecular Analysis of the p53 Alleles in Primary Hepatocellular Carcinomas and Cell Lines. Oncogene, 6, 237-243.</mixed-citation></ref><ref id="scirp.60062-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Le Gall, R., Marchand, C. and Rees, J. (2005) Impacts of Antibiotics on in Vitro UVA-Susceptibility of Human Skin Fibroblasts. European Journal of Dermatology, 15, 146-151.</mixed-citation></ref><ref id="scirp.60062-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Xaiver, J.J.F., Krishnasamy, K. and Sankar, C. (2012) Synthesis and Antibacterial, Antifungal Activities of Some 2r,4c-Diaryl-3-Azabicyclo[3.3.1]Nonan-9-One-4-Aminobenzoyl Hydrazones. Medicinal Chemistry Research, 21, 345- 350. http://dx.doi.org/10.1007/s00044-010-9528-6</mixed-citation></ref></ref-list></back></article>